KY HB490 | 2024 | Regular Session


Spectrum: Moderate Partisan Bill (Republican 14-2)
Status: Introduced on February 8 2024 - 25% progression
Action: 2024-02-27 - reassigned to Appropriations & Revenue (H)
Pending: House Appropriations and Revenue Committee
Text: Latest bill text (Introduced) [PDF]


Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.


AN ACT relating to pharmaceutical drug price discrimination.



2024-02-27Housereassigned to Appropriations & Revenue (H)
2024-02-15Houseto Health Services (H)
2024-02-08Houseto Committee on Committees (H)
2024-02-08Houseintroduced in House


Kentucky State Sources

Bill Comments